Sex Differences in the Anti-Hypertensive Effect of Calcium-Channel Blockers: A Systematic Review and Meta-Analysis
Authors:
- Eveline M. van LuikELEveline M. van Luik
- Esmée W. P. VaesEVEsmée W. P. Vaes
- Maud A. M. VesseurMVMaud A. M. Vesseur
- Nick WilmesNWNick Wilmes
- Daniek A. M. MeijsDMDaniek A. M. Meijs
- Sophie A. J. S. LavenSLSophie A. J. S. Laven
- Zenab Mohseni-AlsalhiZMZenab Mohseni-Alsalhi
- Sander de HaasSHSander de Haas
- Marc E. A. SpaandermanMSMarc E. A. Spaanderman
- Chahinda Ghossein-DohaCGChahinda Ghossein-Doha
Open Access
- 2 June 2023
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 11 (6) , 1622
Abstract
Cardiovascular disease (CVD) is the number one cause of death worldwide, with hypertension as the leading risk factor for both sexes. As sex may affect responsiveness to antihypertensive compounds, guidelines for CVD prevention might necessitate divergence between females and males. To this end, we studied the effectiveness of calcium channel blockers (CCB) on blood pressure (BP), heart rate (HR) and cardiac function between sexes. We performed a systematic review and meta-analysis on studies on CCB from inception to May 2020. Studies had to present both baseline and follow-up measurements of the outcome variables of interest and present data in a sex-stratified manner. Mean differences were calculated using a random-effects model. In total, 38 studies with 8202 participants were used for this review. In females as compared to males, systolic BP decreased by −27.6 mmHg (95%CI −36.4; −18.8) (−17.1% (95%CI −22.5;−11.6)) versus −14.4 mmHg (95%CI −19.0; −9.9) (−9.8% (95%CI −12.9;−6.7)) (between-sex difference p < 0.01), diastolic BP decreased by −14.1 (95%CI −18.8; −9.3) (−15.2%(95%CI −20.3;−10.1)) versus −10.6 mmHg (95%CI −14.0; −7.3) (−11.2% (95%CI −14.8;−7.7)) (between-sex difference p = 0.24). HR decreased by −1.8 bpm (95%CI −2.5; −1.2) (−2.5% (95%CI −3.4; −1.6)) in females compared to no change in males (0.3 bpm (95% CI −1.2; 1.8)) (between-sex difference p = 0.01). In conclusion, CCB lowers BP in both sexes, but the observed effect is larger in females as compared to males.Keywords
This publication has 92 references indexed in Scilit:
- Sex-related differences in pharmacokinetics and pharmacodynamics of anti-hypertensive drugsHypertension Research, 2011
- Gender Differences in Pressure-Natriuresis and Renal AutoregulationHypertension, 2011
- Postmenopausal HypertensionHypertension, 2009
- Use of heart rate spectral analysis to study the effects of calcium channel blockers on sympathetic activity after myocardial infarctionAmerican Heart Journal, 1990
- Felodipine in severe chronic congestive heart failure: Acute effects on central hemodynamics and regional blood flow distributionCardiovascular Drugs and Therapy, 1989
- Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failureAmerican Heart Journal, 1987
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failureAmerican Heart Journal, 1985
- Effects of nifedipine on forearm vascular resistance and venous capacitance in normal subjects and in patients with congestive heart failureInternational Journal of Cardiology, 1985
- Hemodynamic changes associated with long-term antihypertensive therapy with new calcium antagonist.Japanese Heart Journal, 1983